To evaluate the effect of Shaddaranam Gulika Tablet in the management of Rheumatoid Arthritis

A Randomized controlled clinical trial to evaluate the effect of Shaddaranam Gulika Tablet in the management of Amavata ( Rheumatoid Arthritis) - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/08/072718

Enrollment

Registered

2024-08-19

Start date

Unknown

Completion date

Unknown

Last updated

2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M069- Rheumatoid arthritis, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: patient between 18 to 60 years Inflammatory marker like ESR are in elevated sate Anti-CCP positive with or without Radiological changes patient selected as per ACR (American college of rhuematology) and EULAR(EUROPEAN League Against RHEUMATISM 2020

Exclusion criteria

Exclusion criteria: Patients with history of recurrent fractures tumours of bone patients with known history of cardiac diseases pulmonary TB that may interfere with the study Pregnant and lactating women Chronicity more than 5 years

Design outcomes

Primary

Measure	Time frame
Reduction in pain and stiffness in the jointsTimepoint: on day 61	—

Secondary

Measure	Time frame
Reduction in the value of inflammatory markers like CRP,ESR and RA factorTimepoint: on day 61	—

Countries

India

Contacts

Public ContactDr Kajol Hemant Mhatre

Sri Jayendra Saraswathi Ayurveda College and Hospital ,Nazarthpet,Chennai

drsrout@gmail.com8552030926

Outcome results